1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow Moderate to Severe Ulcerative Colitis: new trials by email Literature Review of Moderate to Severe Ulcerative Colitis trials Research Report on Moderate to Severe Ulcerative Colitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Activity, and Safety of Vixarelimab in Participants With Moderate to Severe Active Ulcerative Colitis Vixarelimab - Moderate to Severe Ulcerative Colitis | Phase 1 | Completed | Genentech, Inc. | 24 | 2025-03-31 | 2026-09-21 |
Genentech, Inc. (1)
Germany (1)